Concepedia

Mitchell Rosenberg

MR

Statistics

Publications

14

Citations

1.7K

H-Index

13

Active since

1990

Affiliations

Novartis (United States)(Current)

Beth Israel Deaconess Hospital

Brigham and Women's Hospital

Novartis (Switzerland)

Harvard University

Mitchell Rosenberg is an author at Novartis (United States) specializing in pharmacology, clinical pharmacology, and pharmacy.

Publications per year

1990–2009

14

Publications

14

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

Elliot Israel, Andrew R. Fischer, Mitchell Rosenberg et al. · American Review of Respiratory Disease · 1993 · 377 citations

, , +12

The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry Air

Elliot Israel, Robert Dermarkarian, Mitchell Rosenberg et al. · New England Journal of Medicine · 1990 · 372 citations · Full text

, , +17

Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma

Andrew R. Fischer, Mitchell Rosenberg, Craig M. Lilly et al. · Journal of Allergy and Clinical Immunology · 1994 · 167 citations

, , +16

Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model

Dennis G. Fryback, N. K. Stout, Mitchell Rosenberg et al. · JNCI Monographs · 2006 · 165 citations · Full text

, , +17

Induction and Expression of Human Cartilage Glycoprotein 39 in Rheumatoid Inflammatory and Peripheral Blood Monocyte-Derived Macrophages

Robert B. Kirkpatrick, Jennifer Emery, Jennie Connor et al. · Experimental Cell Research · 1997 · 117 citations

, , +16

1–5 of 14